Publication: Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis
| dc.contributor.author | Weerawat Manosuthi | en_US |
| dc.contributor.author | Kiat Ruxrungtham | en_US |
| dc.contributor.author | Sirirat Likanonsakul | en_US |
| dc.contributor.author | Wisit Prasithsirikul | en_US |
| dc.contributor.author | Yaowarat Inthong | en_US |
| dc.contributor.author | Thanongsri Phoorisri | en_US |
| dc.contributor.author | Somnuek Sungkanuparph | en_US |
| dc.contributor.other | Thailand Ministry of Public Health | en_US |
| dc.contributor.other | Chulalongkorn University | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.contributor.other | Bamrasnaradura Infectious Disease Institute | en_US |
| dc.date.accessioned | 2018-08-24T02:13:00Z | |
| dc.date.available | 2018-08-24T02:13:00Z | |
| dc.date.issued | 2007-01-01 | en_US |
| dc.description.abstract | Seventy patients with human immunodeficiency virus (HIV) and tuberculosis coinfection who initiated nevirapine-based antiretroviral therapy and had trough nevirapine levels determined while receiving rifampicin were enrolled in a study. After discontinuation of rifampicin therapy, mean nevirapine levels (± standard deviation) increased from 5.4 ± 3.5 mg/L to 6.4 ± 3.4 mg/L (P = .047), but no nevirapine-related adverse events occurred. There was no statistically significant difference in 60-week antiviral efficacy between these patients and patients receiving nevirapine-based antiretroviral therapy alone (P > .05). © 2006 by the Infectious Diseases Society of America. All rights reserved. | en_US |
| dc.identifier.citation | Clinical Infectious Diseases. Vol.44, No.1 (2007), 141-144 | en_US |
| dc.identifier.doi | 10.1086/510078 | en_US |
| dc.identifier.issn | 10584838 | en_US |
| dc.identifier.other | 2-s2.0-33845720528 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/25080 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33845720528&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33845720528&origin=inward | en_US |